IL160286A0 - Angiotensin peptide-carrier conjugates and uses thereof - Google Patents

Angiotensin peptide-carrier conjugates and uses thereof

Info

Publication number: IL160286A0
Authority: IL; Israel
Prior art keywords: conjugates; angiotensin; carrier conjugates; angiotensin peptide; peptide
Prior art date: 2001-10-05

Application number

IL16028602A

Other languages

English (en)

Original Assignee

Cytos Biotechnology Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-05

Filing date

2002-10-07

Publication date

2004-07-25

2002-01-18 Priority claimed from US10/050,902 external-priority patent/US7264810B2/en

2002-10-07 Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag

2002-10-07 Priority claimed from PCT/EP2002/011219 external-priority patent/WO2003031466A2/en

2004-07-25 Publication of IL160286A0 publication Critical patent/IL160286A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Vascular Medicine (AREA)
Microbiology (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL16028602A 2001-10-05 2002-10-07 Angiotensin peptide-carrier conjugates and uses thereof IL160286A0 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US32699801P	2001-10-05	2001-10-05
US33104501P	2001-11-07	2001-11-07
US10/050,902 US7264810B2 (en)	2001-01-19	2002-01-18	Molecular antigen array
PCT/IB2002/000166 WO2002056905A2 (en)	2001-01-19	2002-01-21	Molecular antigen array
US39663702P	2002-07-19	2002-07-19
PCT/EP2002/011219 WO2003031466A2 (en)	2001-10-05	2002-10-07	Angiotensin peptide-carrier conjugates and uses thereof

Publications (1)

Publication Number	Publication Date
IL160286A0 true IL160286A0 (en)	2004-07-25

Family

ID=32996249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16028602A IL160286A0 (en)	2001-10-05	2002-10-07	Angiotensin peptide-carrier conjugates and uses thereof

Country Status (10)

Country	Link
EP (1)	EP2090319A3 (da)
JP (1)	JP2010189406A (da)
KR (1)	KR101015508B1 (da)
AT (1)	ATE421334T1 (da)
BR (1)	BR0213117A (da)
DE (1)	DE60230992D1 (da)
DK (1)	DK1432443T3 (da)
IL (1)	IL160286A0 (da)
MX (1)	MXPA04002644A (da)
PL (1)	PL369796A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9446120B2 (en) *	2011-04-15	2016-09-20	Osaka University	DNA vaccine
US10526376B2 (en)	2015-01-15	2020-01-07	University Of Copenhagen	Virus-like particle with efficient epitope display
EP3368068B1 (en)	2015-10-30	2020-11-18	University of Copenhagen	Virus like particle with efficient epitope display
US12194157B2 (en)	2020-04-09	2025-01-14	Finncure Oy	Carrier for targeted delivery to a host
AU2021252164A1 (en)	2020-04-09	2022-12-15	Finncure Oy	Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722840A (en)	1984-09-12	1988-02-02	Chiron Corporation	Hybrid particle immunogens
US4918166A (en)	1987-04-10	1990-04-17	Oxford Gene Systems Limited	Particulate hybrid HIV antigens
NZ235315A (en)	1989-09-19	1991-09-25	Wellcome Found	Chimaeric hepadnavirus core antigen proteins and their construction
ES2284161T3 (es)	1990-01-12	2007-11-01	Amgen Fremont Inc.	Generacion de anticuerpos xenogenicos.
US5334394A (en)	1990-06-22	1994-08-02	The Regents Of The University Of California	Human immunodeficiency virus decoy
SE9003978D0 (sv)	1990-12-13	1990-12-13	Henrik Garoff	Dna expressionssystem baserade paa ett virus replikon
GB9101550D0 (en)	1991-01-24	1991-03-06	Mastico Robert A	Antigen-presenting chimaeric protein
GB9114003D0 (en)	1991-06-28	1991-08-14	Mastico Robert A	Chimaeric protein
GB9227068D0 (en)	1992-12-29	1993-02-24	British Bio Technology	Novel proteinaceous particles
AU6172194A (en)	1993-02-08	1994-08-29	Paravax, Inc.	Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
US5876727A (en)	1995-03-31	1999-03-02	Immulogic Pharmaceutical Corporation	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
WO1996030523A2 (en)	1995-03-31	1996-10-03	Hans Wolf	Antigen presentation system based on retrovirus-like particles
US5792462A (en)	1995-05-23	1998-08-11	University Of North Carolina At Chapel Hill	Alphavirus RNA replicon systems
ID18046A (id)	1996-08-20	1998-02-19	Takeda Chemical Industries Ltd	Senyawa siklik campuran, pembuatan dan penngunaannya.
US5770380A (en)	1996-09-13	1998-06-23	University Of Pittsburgh	Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
AU748903B2 (en)	1997-06-24	2002-06-13	Proteus Molecular Design Limited	Angiotensin derivatives
ATE249240T1 (de)	1998-02-12	2003-09-15	Immune Complex Corp	Strategisch modifizierte hepatitis b kernproteine und ihre derivate
SE9801923D0 (sv)	1998-05-29	1998-05-29	Independent Pharmaceutical Ab	Nicotine vaccine
ATE314095T1 (de)	1998-10-21	2006-01-15	Us Health	Virusähnliche partikel zur induktion von autoantikörpern
PL192016B1 (pl)	1998-11-30	2006-08-31	Cytos Biotechnology Ag	Kompozycja, sposób wytwarzania sztucznego, uporządkowanego i powtarzalnego układu antygenu, zastosowanie kompozycji oraz kompozycja szczepionki
WO2001077158A1 (en)	2000-04-07	2001-10-18	University Of Leeds Innovations Limited	Hepatitis b core antigen fusion proteins
WO2001085208A2 (en)	2000-05-05	2001-11-15	Cytos Biotechnology Ag	Molecular antigen arrays and vaccines
EP1294893B1 (en)	2000-06-22	2006-03-15	UCB Pharma Limited	Modification of hepatitis b core antigen
US20030138769A1 (en)	2000-08-16	2003-07-24	Birkett Ashley J.	Immunogenic HBc chimer particles having enhanced stability
US7320793B2 (en)	2001-01-19	2008-01-22	Cytos Biotechnology Ag	Molecular antigen array

2002
- 2002-01-21 MX MXPA04002644A patent/MXPA04002644A/es active IP Right Grant
- 2002-01-21 BR BR0213117-0A patent/BR0213117A/pt not_active IP Right Cessation
- 2002-10-07 PL PL02369796A patent/PL369796A1/xx not_active Application Discontinuation
- 2002-10-07 DE DE60230992T patent/DE60230992D1/de not_active Expired - Lifetime
- 2002-10-07 KR KR1020047002222A patent/KR101015508B1/ko not_active Expired - Fee Related
- 2002-10-07 AT AT02800605T patent/ATE421334T1/de not_active IP Right Cessation
- 2002-10-07 IL IL16028602A patent/IL160286A0/xx not_active IP Right Cessation
- 2002-10-07 DK DK02800605T patent/DK1432443T3/da active
- 2002-10-07 EP EP09150826A patent/EP2090319A3/en not_active Withdrawn
2010
- 2010-04-01 JP JP2010085112A patent/JP2010189406A/ja active Pending

Also Published As

Publication number	Publication date
DK1432443T3 (da)	2009-05-04
JP2010189406A (ja)	2010-09-02
DE60230992D1 (de)	2009-03-12
EP2090319A2 (en)	2009-08-19
KR101015508B1 (ko)	2011-02-16
BR0213117A (pt)	2004-09-21
PL369796A1 (en)	2005-05-02
MXPA04002644A (es)	2004-07-08
KR20050034573A (ko)	2005-04-14
EP2090319A3 (en)	2009-10-28
HK1067057A1 (en)	2005-04-01
ATE421334T1 (de)	2009-02-15

Legal Events

Date	Code	Title
2010-11-30	FF	Patent granted
2010-11-30	KB	Patent renewed
2012-10-31	KB	Patent renewed
2017-05-29	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
WO2003031466A3 (en)	2003-10-23	Angiotensin peptide-carrier conjugates and uses thereof
PL366826A1 (en)	2005-02-07	Reducing the immunogenicity of fusion proteins
AU2002355677A1 (en)	2003-02-17	Antigenic polypeptides
MXPA04006059A (es)	2004-09-27	Preparacion liofilizada que contiene anticuerpos contra el receptor del factor de crecimiento epidermico.
MY162525A (en)	2017-06-15	Process for concentration of antibodies and therapeutic products thereof
EP1553975B8 (en)	2023-04-12	Optimized fc variants and methods for their generation
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
ATE252814T1 (de)	2003-11-15	Leuchstoff für lichtquellen und zugehörige lichtquelle
AP2003002752A0 (en)	2003-06-30	Immunogenic HBc Chimer particles having enhanced stability.
IL149459A0 (en)	2002-11-10	Recombinant gelatins
AP2003002751A0 (en)	2003-06-30	Malaria immunogen and vaccine
GB0016040D0 (en)	2000-08-23	Novel process for preparing crystalline particles
GB0015981D0 (en)	2000-08-23	Novel process for preparing crystalline particles
MXPA03007450A (es)	2004-07-30	Metodos para producir dioxido de titanio practicamente libre de anatasa, con adicion de haluro de silicio.
DE50005586D1 (de)	2004-04-15	Leuchtstoff für Lichtquellen und zugehörige Lichtquelle
ATE320493T1 (de)	2006-04-15	Modifizierung des hepatitis b kernantigens
MY127575A (en)	2006-12-29	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
YU61103A (sh)	2006-05-25	Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
PL369796A1 (en)	2005-05-02	Angiotensin peptide-carrier conjugates and uses thereof
ATE262600T1 (de)	2004-04-15	Herstellung von aluminium-silizium-legierungen
WO2003072731A3 (en)	2005-02-10	STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS
MXPA03007992A (es)	2004-09-29	Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion
SG185137A1 (en)	2012-11-29	Biologically active peptides
MXPA04004937A (es)	2004-08-11	Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
DE59610629D1 (de)	2003-09-04	Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine